Physician profile
Jeffery K Harpstrite
NPI 1952413973
$152,676.07
in general payments reported to CMS, 2019-2025
13 companies · $33K in 2025
The $33K reported for 2025 was more than what 93% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $30K · 2021: $9,953 · 2022: $27K · 2023: $5,335 · 2024: $318 · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Travel and Lodging: $5,553 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,045 · Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,612.50 |
| Travel and Lodging | $5,553.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,045.00 |
| Food and Beverage | $1,160.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $125,879.08 | 2019-2025 | Journey II, Real Intelligence, Journey II Xr |
| Ortho Development Corporation | $20,025.06 | 2019-2020 | |
| Medtronic, INC. | $3,585.70 | 2021-2023 | Aquamantys(Tm) |
| Impactortho, INC. | $1,300.00 | 2021-2022 | |
| Bioventus LLC | $1,156.81 | 2021-2022 | |
| Orthalign INC | $215.24 | 2019 | |
| Medtronic USA, INC. | $192.38 | 2019-2020 | |
| Medacta USA, INC. | $131.19 | 2019 | |
| Stryker Corporation | $70.94 | 2022 | |
| Orthofix Medical, INC. | $64.72 | 2023-2025 | Physio-Stim |
| Kowa Pharmaceuticals America, INC. | $22.51 | 2023 | Seglentis |
| Becton, Dickinson and Company | $17.30 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Harpstrite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.